<VariationArchive VariationID="640066" VariationName="NM_001282225.2(ADA2):c.144del (p.Arg49fs)" VariationType="Deletion" Accession="VCV000640066" Version="10" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2019-08-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="649174" VariationID="640066">
      <GeneList>
        <Gene Symbol="ADA2" FullName="adenosine deaminase 2" GeneID="51816" HGNC_ID="HGNC:1839" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q11.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="17178790" stop="17221848" display_start="17178790" display_stop="17221848" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="17660191" stop="17690778" display_start="17660191" display_stop="17690778" Strand="-" />
          </Location>
          <OMIM>607575</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001282225.2(ADA2):c.144del (p.Arg49fs)</Name>
      <CanonicalSPDI>NC_000022.11:17209533:CCCCCCC:CCCCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q11.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="17209534" stop="17209534" display_start="17209534" display_stop="17209534" variantLength="1" positionVCF="17209533" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="17690424" stop="17690424" display_start="17690424" display_stop="17690424" variantLength="1" positionVCF="17690423" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>NM_001282225.2(ADA2):c.144del</Name>
        <Name>p.Arg49fs</Name>
      </OtherNameList>
      <ProteinChange>R49fs</ProteinChange>
      <ProteinChange>R7fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282225.1" sequenceAccession="NM_001282225" sequenceVersion="1" change="c.144del">
            <Expression>NM_001282225.1:c.144del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.17690430del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.17690430del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.17209540del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.17209540del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033943.1" sequenceAccession="NG_033943" sequenceVersion="1" change="g.17321del">
            <Expression>NG_033943.1:g.17321del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282225.2" sequenceAccession="NM_001282225" sequenceVersion="2" change="c.144del" MANESelect="true">
            <Expression>NM_001282225.2:c.144del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269154.1" sequenceAccession="NP_001269154" sequenceVersion="1" change="p.Arg49fs">
            <Expression>NP_001269154.1:p.Arg49fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282226.2" sequenceAccession="NM_001282226" sequenceVersion="2" change="c.144del">
            <Expression>NM_001282226.2:c.144del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269155.1" sequenceAccession="NP_001269155" sequenceVersion="1" change="p.Arg49fs">
            <Expression>NP_001269155.1:p.Arg49fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282227.2" sequenceAccession="NM_001282227" sequenceVersion="2" change="c.18del">
            <Expression>NM_001282227.2:c.18del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269156.1" sequenceAccession="NP_001269156" sequenceVersion="1" change="p.Arg7fs">
            <Expression>NP_001269156.1:p.Arg7fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282228.2" sequenceAccession="NM_001282228" sequenceVersion="2" change="c.18del">
            <Expression>NM_001282228.2:c.18del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269157.1" sequenceAccession="NP_001269157" sequenceVersion="1" change="p.Arg7fs">
            <Expression>NP_001269157.1:p.Arg7fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282229.2" sequenceAccession="NM_001282229" sequenceVersion="2" change="c.-38-2244del">
            <Expression>NM_001282229.2:c.-38-2244del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1217" sequenceAccession="LRG_1217">
            <Expression>LRG_1217:g.17321del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1217t1" sequenceAccession="LRG_1217t1">
            <Expression>LRG_1217t1:c.144del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1217p1" sequenceAccession="LRG_1217p1" change="p.Arg49fs">
            <Expression>LRG_1217p1:p.Arg49fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="756881285" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001282225.2(ADA2):c.144del (p.Arg49fs) AND Vasculitis due to ADA2 deficiency" Accession="RCV000793011" Version="11">
        <ClassifiedConditionList TraitSetID="13385">
          <ClassifiedCondition DB="MedGen" ID="C3887654">Vasculitis due to ADA2 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001282225.2(ADA2):c.144del (p.Arg49fs) AND multiple conditions" Accession="RCV002487649" Version="1">
        <ClassifiedConditionList TraitSetID="35862">
          <ClassifiedCondition DB="MedGen" ID="C0282492">Sneddon syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3887654">Vasculitis due to ADA2 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-20" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2019-08-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24552284</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24552285</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27059682</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28522451</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="35862" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6159" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Polyarteritis nodosa, childhoood-onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Vasculitis due to ADA2 deficiency</ElementValue>
                <XRef ID="MONDO:0014306" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VAIHS</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12383" />
                <XRef ID="12383" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Adenosine deaminase 2 deficiency (DADA2) is a complex systemic autoinflammatory disorder in which vasculopathy/vasculitis, dysregulated immune function, and/or hematologic abnormalities may predominate. Inflammatory features include intermittent fevers, rash (often livedo racemosa/reticularis), and musculoskeletal involvement (myalgia/arthralgia, arthritis, myositis). Vasculitis, which usually begins before age ten years, may manifest as early-onset ischemic (lacunar) and/or hemorrhagic strokes, or as cutaneous or systemic polyarteritis nodosa. Hypertension and hepatosplenomegaly are often found. More severe involvement may lead to progressive central neurologic deficits (dysarthria, ataxia, cranial nerve palsies, cognitive impairment) or to ischemic injury to the kidney, intestine, and/or digits. Dysregulation of immune function can lead to immunodeficiency or autoimmunity of varying severity; lymphadenopathy may be present and some affected individuals have had lymphoproliferative disease. Hematologic disorders may begin early in life or in late adulthood, and can include lymphopenia, neutropenia, pure red cell aplasia, thrombocytopenia, or pancytopenia. Of note, both interfamilial and intrafamilial phenotypic variability (e.g., in age of onset, frequency and severity of manifestations) can be observed; also, individuals with biallelic ADA2 pathogenic variants may remain asymptomatic until adulthood or may never develop clinical manifestations of DADA2.</Attribute>
                <XRef ID="NBK544951" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31393689</ID>
                <ID Source="BookShelf">NBK544951</ID>
              </Citation>
              <XRef ID="404553" DB="Orphanet" />
              <XRef ID="C3887654" DB="MedGen" />
              <XRef ID="MONDO:0014306" DB="MONDO" />
              <XRef Type="MIM" ID="615688" DB="OMIM" />
            </Trait>
            <Trait ID="4405" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Idiopathic livedo reticularis with systemic involvement</ElementValue>
                <XRef ID="238776001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sneddon syndrome</ElementValue>
                <XRef ID="MONDO:0008436" DB="MONDO" />
                <XRef ID="716745004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sneddon's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Livedo reticularis and cerebrovascular accidents</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebro-vascular lesions and livedo reticularis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SNDNS</ElementValue>
                <XRef Type="MIM" ID="182410" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7664" />
                <XRef ID="7664" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="820" DB="Orphanet" />
              <XRef ID="C0282492" DB="MedGen" />
              <XRef ID="MONDO:0008436" DB="MONDO" />
              <XRef Type="MIM" ID="182410" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13385" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6159" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Polyarteritis nodosa, childhoood-onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Vasculitis due to ADA2 deficiency</ElementValue>
                <XRef ID="MONDO:0014306" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VAIHS</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12383" />
                <XRef ID="12383" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Adenosine deaminase 2 deficiency (DADA2) is a complex systemic autoinflammatory disorder in which vasculopathy/vasculitis, dysregulated immune function, and/or hematologic abnormalities may predominate. Inflammatory features include intermittent fevers, rash (often livedo racemosa/reticularis), and musculoskeletal involvement (myalgia/arthralgia, arthritis, myositis). Vasculitis, which usually begins before age ten years, may manifest as early-onset ischemic (lacunar) and/or hemorrhagic strokes, or as cutaneous or systemic polyarteritis nodosa. Hypertension and hepatosplenomegaly are often found. More severe involvement may lead to progressive central neurologic deficits (dysarthria, ataxia, cranial nerve palsies, cognitive impairment) or to ischemic injury to the kidney, intestine, and/or digits. Dysregulation of immune function can lead to immunodeficiency or autoimmunity of varying severity; lymphadenopathy may be present and some affected individuals have had lymphoproliferative disease. Hematologic disorders may begin early in life or in late adulthood, and can include lymphopenia, neutropenia, pure red cell aplasia, thrombocytopenia, or pancytopenia. Of note, both interfamilial and intrafamilial phenotypic variability (e.g., in age of onset, frequency and severity of manifestations) can be observed; also, individuals with biallelic ADA2 pathogenic variants may remain asymptomatic until adulthood or may never develop clinical manifestations of DADA2.</Attribute>
                <XRef ID="NBK544951" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31393689</ID>
                <ID Source="BookShelf">NBK544951</ID>
              </Citation>
              <XRef ID="404553" DB="Orphanet" />
              <XRef ID="C3887654" DB="MedGen" />
              <XRef ID="MONDO:0014306" DB="MONDO" />
              <XRef Type="MIM" ID="615688" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5429493" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_001282225.2:c.144del|OMIM:182410;615688" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002776723" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001282225.2:c.144del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="182410" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615688" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7332460" SubmissionDate="2023-05-03" DateLastUpdated="2023-05-06" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="27c96dbb-e63c-4132-b6cb-1c0e6cbd20d7" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003922186" DateUpdated="2023-05-06" DateCreated="2023-05-06" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous p.Arg49GlyfsTer4 variant in ADA2 was identified by our study, in the compound heterozygous state with a likely pathogenic variant (ClinVar Variation ID: 624611), in one individual with vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome. Trio exome analysis revealed that this variant was in trans with a likely pathogenic variant (ClinVar Variation ID: 624611). The p.Arg49GlyfsTer4 variant in ADA2 has been previously reported in 4 unrelated individuals with vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (PMID: 32909274, PMID: 35804211, PMID: 28522451, PMID: 27059682) and segregated with disease in 2 affected relatives from one family (PMID: 35804211), but has been identified in 0.007% (3/41374) of African/African American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs756881285). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. Of these 4 previously reported unrelated individuals (PMID: 32909274, PMID: 35804211, PMID: 28522451, PMID: 27059682), one was a homozygote (PMID: 35804211) and two were compound heterozygotes who carried pathogenic or likely pathogenic variants in trans (PMID: 27059682, ClinVar Variation ID: 1407177; PMID: 28522451, ClinVar Variation ID 189342), which increases the likelihood that the p.Arg49GlyfsTer4 variant is pathogenic. This variant has also been reported in ClinVar (Variation ID: 640066) and has been interpreted as pathogenic by Invitae and Fulgent Genetics. This variant is predicted to cause a frameshift, which alters the protein‚Äôs amino acid sequence beginning at position 49 and leads to a premature termination codon 4 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the ADA2 gene is strongly associated to autosomal recessive vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome. ACMG/AMP Criteria applied: PVS1_Strong, PM2_Supporting, PM3_Strong (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001282225.2(ADA2):c.144del</Name>
            <Name>p.Arg49fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.11:g.17209540del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0014306" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13232620</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1826122" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4962473|MedGen:C3887654" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000932344" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24552284</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24552285</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27059682</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28522451</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg49Glyfs*4) in the ADA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ADA2 are known to be pathogenic (PMID: 24552284, 24552285). This variant is present in population databases (rs780731346, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with polyarteritis nodosa or symptoms consistent with polyarteritis nodosa (PMID: 27059682, 28522451). This variant is also known as c.138/144delG. ClinVar contains an entry for this variant (Variation ID: 640066). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.17690424del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3887654" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1826122" TraitType="Disease" MappingType="XRef" MappingValue="C3887654" MappingRef="MedGen">
        <MedGen CUI="C3887654" Name="Vasculitis due to ADA2 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7332460" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0014306" MappingRef="MONDO">
        <MedGen CUI="C3887654" Name="Vasculitis due to ADA2 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429493" TraitType="Disease" MappingType="XRef" MappingValue="615688" MappingRef="OMIM">
        <MedGen CUI="C3887654" Name="Vasculitis due to ADA2 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429493" TraitType="Disease" MappingType="XRef" MappingValue="182410" MappingRef="OMIM">
        <MedGen CUI="C0282492" Name="Sneddon syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

